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ABSTRACT
Amphotericin B is an antibiotic used in the treatment of fungal disease and leishmania; 
however, it exhibits side effects to patients, hindering its wider application. Therefore, 
nanocarriers have been investigated as delivery systems for amphotericin B (AMB) in 
order to decrease its toxicity, besides increase bioavailability and solubility. 
Amphiphilic copolymers are interesting materials to encapsulate hydrophobic drugs 
such as AMB, hence copolymers of cashew gum (CG) and L-lactide (LA) were 
synthesized using two different CG:LA molar ratios (1:1 and 1:10). Data obtained 
revealed that copolymer nanoparticles present similar figures for particle sizes and zeta 
potentials; however, particle size of encapsulated AMB increases if compared to 
unloaded nanoparticles. The 1:10 nanoparticle sample has better stability although 
higher polydispersity index (PDI) if compared to 1:1 sample.  High amphotericin 
(AMB) encapsulation efficiencies and low hemolysis were obtained. AMB loaded 
copolymers show lower aggregation pattern than commercial AMB solution. AMB 
loaded nanoparticles show antifungal activities against four C. albicans strains. It can be 
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Amphiphilic polymers have been widely investigated as drug delivery system due to 
their ability to form nanoparticles by self-assembly. The hydrophobic core of 
amphiphilic nanoparticles can incorporate hydrophobic drugs and delivery them to 
specific targets [1,2].
Polysaccharides have been used as matrix building blocks to produced amphiphilic 
materials through the insertion of hydrophobic groups or the grafting of hydrophobic 
monomers onto polysaccharide chains. The choice of polysaccharide is based on its 
properties (biodegradability and non-toxicity) and the source material (renewable 
resource) as well as the presence of several chemical groups, such as hydroxyl, sulfate, 
amino and carboxyl, which can be used to promote the synthesis.
Lactic acid is obtained by microbial fermentation and source materials include corn 
syrup, sucrose from sugar cane, lactose cheese pulp and paper [3,4]. Poly (lactic acid) 
(PLA) is biocompatible, bio-absorbable and biodegradable and it has been approved by 
the US Food and Drug Administration (FDA) as a biomaterial [5,6]. Copolymers of 
PLA and polysaccharides, such as cellulose, starch, chitosan and pullulan have been 
reported [7-16]. Recent studies have addressed synthesis methods and applications as 
well as the development of potential delivery systems for hydrophobic drugs, due to the 
capacity to form amphiphilic micelles through self-organization [7-16].
Cashew gum (CG) is an exudate polysaccharide obtained from the Anacardium 
occidentale tree, which shows the potential for commercial use due to the large 
plantations of these trees in Brazil and in other countries [17]. The number of articles 
published on cashew gum has increase significantly in the past decade. The gum is a 
branched macromolecule mainly composed of three types of galactan units within the 
core, linked by C-1 and C-3; C-1 and C-6; and C-1, C-3 and C-6 [18,19]. Copolymers 
of CG with monomers such as acrylamide [20-24]; acrylic acid [25] and 
isopropylacrylamide [26]have been reported.
CG gum has also been cited as a potential drug delivery system for epirubicin [26], 
astaxanthin [27], diclofenac diethyl amine [28], indomethacin [29,30], bovine serum 
albumin (BSA) [31], pilocarpine [32], isoxsuprine HCl [33], alkaloid epiisopiloturine 




























































Richter et al, 2018 [36] reported proof-of-concept of the feasibility to prepare 
Pickering emulsion systems based on copolymer derivative of cashew gum and L-
polylactide. The systems offered the possibility to associate AMB with encapsulation 
efficiencies up to 47 %, however the synthesis and characterization of copolymer 
neither the production and characterization of nanoparticles by self-assembling were 
reported. 
Amphotericin B (AMB) was the drug selected to be loaded into the self-assembled 
nanoparticles. AMB is a potent fungistatic and fungicide drug produced by the 
actinomycetes Streptomycetes nodosus [37] that was approved for clinical use by FDA 
in 1959 [38]. AMB is also prescribed in the treatment of visceral leishmaniasis. It is a 
lipophilic drug that binds to lipids and intercalates into lipid bilayers that then associate 
to form transmembrane pores [39]. AMB also shows very low oral bioavailability due 
to its structural features that violate Lipinsky’s rule (e.g., low Log P, high Mw, large 
polar surface area). Hence, novel pharmaceutical formulations of AMB are of great 
interest with a view to contribute to increase its pharmacological bioavailability for oral 
and other routes of administration, while exerting control on its drug release.
Many authors have proposed new encapsulation techniques for AMB in order to 
decrease its side effects and toxicity, such as: nanoparticles [40-43], micelles [44,45], 
conjugates [46] and emulsions [36,47,48].
In this study, cashew gum/polylactide copolymers (CGPLAP) with different 
CG:PLA molar ratios have been synthesize and characterized by resonance magnetic 
nuclear (RMN) and infrared spectroscopy. The effect of copolymer composition on 
physicochemical characteristics of AMB loaded and unloaded nanoparticles obtained by 




Cashew tree (Anacardium occidentale) exudate was kindly donated by EMBRAPA 
(Empresa Brasileira de Pesquisa Agropecuária) and the cashew gum (CG) was isolated 
as described in a previously paper [18]. L-Lactide (3,6-dimethyl-1,4-dioxane-2,5-dione), 




























































and used without further purification. The cashew gum used in this study has an average 
molar mass, obtained by size exclusion chromatography, of 6.9 x104 g.mol-1 and the 
molar sugar ratio for galactose:glucose:arabinose:rhamnose:glucuronic acid was 
determined as 1.00:0.20:0.08:0.05:0.06.
2.2. Cashew gum/lactide copolymer (CGPLAP)
The copolymers were synthesized as previously reported by Seo et al. [13]. Briefly, 
1.0 g of CG was dissolved in DMSO in the temperature range of 70-75°C,under 
magnetic stirring. L-Lactide and TEA were added to the flask (the amounts of reagents 
and solvent are given in Table 1) and the reaction was kept under N2 atmosphere for 2 h. 
After this time, the N2 flow was interrupted and the reaction was left to proceed for 10 
h. At the end of the reaction time, the copolymer solution was filtered, dialyzed against 
water and lyophilized. The graft reaction was performed in two CG:PLA molar ratios 
(1:1 and 1:10). In this methodology, the concentration of lactide and TEA was kept at 
10 and 2% (w/v), respectively. To remove residual monomer and/or homopolymer 
formed during the reaction, hexane was added to the lyophilized graft copolymers 
dispersed in distilled water and the system was kept under magnetic stirring for 48 h 
[49]. After this period of time, the aqueous phase was removed and lyophilized. The 
purified samples were named CGPLAP.
2.3. Characterization of cashew gum copolymer
The Fourier transform IR (FT-IR) spectra were recorded on an FTLA 2000, ABB 
Bomem spectrometer, in the range of 400 - 4000 cm-1, with the samples as KBr pellet. 
1H NMR spectra were recorded in DMSO-d6 at 353 K on a Fourier transform Bruker 
Advance DRX 500 spectrometer with an inverse multinuclear gradient probehead 
equipped with z-shielded gradient coils and a Silicon Graphics workstation.  The molar 
substitution (MS), degree of substitution (DS) and degree of polymerization (DP) were 
calculated based on procedures reported in the literature by Guo et al. [5] and Teramoto 




























































MS =                                                                                                                   
(𝐴+ 𝐵)/3𝐻 ‒ 1
(1)
DS=                                                                                                     (2)
𝐴/3𝐻 ‒ 1
DP =                                                                                                      (3)
𝑀𝑆𝐷𝑆
where A and B are the area of terminal and internal methyl groups, respectively, and H-
1 is the area of anomeric protons (5.04 to 5.17 ppm).
2.4. Self-assembled nanoparticles
Self-assembled nanoparticleswere prepared by the dialysis method. GCPLAP (10 
mg) was dissolved in 10 mL of dimethyl sulfoxide (DMSO) and the solution was 
dialyzed against distilled water using a dialysis membrane (cut off 14,000 g.mol-1 ) for 3 
days. The resulting nanoparticles were stored in a freezer until characterization. 
2.5. Particle size 
The size and zeta potential nanoparticles were characterized by dynamic light 
scattering with non-invasive back scattering (DLS-NIBS), at 25ºC,with irradiation of 
the sample using a 4 mW helium/neon red laser (=633 nm). The detection was carried 
out at an angle of 173°. The zeta potential was measured by mixed laser Doppler 
velocimetry and phase analysis light scattering (M3–PALS). A Nanosizer ZS 3600 
system (Malvern Instruments Ltd., Worcestershire, UK) was used for both 
determinations.
2.6 Stability Study
The stability experiment was performed with blank nanoparticles. The stability was 
carried out in phosphate buffer solution (pH 7.4) at 37 ºC. The buffer (950 µL) was 




























































ºC with stirring at 50 rpm. After 20 min, the particle size was measured and this analysis 
was repeated every 20 min until 360 min.Measurements were made in triplicates. 
2.7. Morphology
The morphology of CGPLAP nanoparticles was examined using scanning electron 
microscopy (SEM) and atomic force microscopy (AFM). CGPLAP nanoparticles were 
examined using scanning electron microscopy (Quanta FEG 450 - FEI) at a voltage of 
20 kV. The nanoparticles solutions were fixed in stubs with carbon tape and metallized 
with gold (Quorum QT150ES).
Blank NP´s were analyzed using Asylum MFP3D-Bio microscopy (AFM). The 
images were taken in tapping mode, using an EconoLTESP with nominal spring 
constant of 5n/m and resonance frequency of 138 Khz. Images acquired in intermittent 
contact mode (tapping mode). 10 μL of diluted samples (1:200 v/v) was spread onto 
freshly cleaned mica and vacuum dried. 
2.8. AmphotericinB encapsulation and aggregation state
An amount of 50 mg of the copolymer and 5 mg of AMBwere solubilized in 5 mL of 
DMSO. The solution with the drug was dialyzed for 72 h against distilled water in a 
light-protected vessel. For a determination of encapsulation efficiency(EE%), NP's were 
frozen and lyophilized. The material in powder form was resuspended in DMSO and 
centrifuged at 40,000 G for 0.5 h so that the matrix of the nanoparticle ruptured and 
released the encapsulated drug. After centrifugation the AMBconcentration was 
determined by spectrophotometry in visible ultraviolet (UV-vis) without wavelength of 
391 nm, using a Shimadzu® UV-1800 spectrophotometer.
The amount of AMBencapsulated was calculated using a calibration curve to 
determine the ratio of absorbance to concentration (R2 = 0.9988). The following 
formula was used to calculate EE%:
EE% =
AMB mass in NP





























































To determinate the state of aggregation of AMB in nanoparticles before extraction, 
the AMB loaded nanoparticles were diluted in deionized water and the UV/vis spectrum 
registered. The experiment was also performed with a commercial Sigma AMB solution 
(with sodium desoxycholate). 
2.9 Hemolysis assay
To evaluate the toxicity of self-assembling nanoparticles, its hemolytic activity was 
tested using human red bloods cells (RBCs). Human bloods was collected in EDTA 
tubes, washed three times and re-suspended with sterile saline solution (0.9 %). The 
samples were tested at different AMBconcentration from 62.5 to 250 µg.mL-1. Triton X 
and saline solution were used was positive and negative hemolysis control, respectively. 
The mixture was incubated for 30 min at 37 °C and centrifuged at 8,000 rpm for 1 min. 
After centrifugation time, the absorbance of samples supernatant was measured at 492 
nm. The results were statistically compared by Tukey test (p < 0.05), using Statistical 
10.0 program. 
2.10 In vitro drug release
The release profiles of the drug loaded nanoparticles were obtained using a dialysis 
system. Each nanoparticle sample (20 mg) were introduced into cellulose acetate 
membranes (cut off 14,000 g.mol-1) and dialyzed against 30 mL of PBS buffer solution 
containing 0.25% sodium lauryl sulfate, at pH 7.4, and 37 °C. Aliquots were taken at 
certain time intervals and analyzed by spectrophotometry in the UV–vis region. 
2.11In vitro antifungal activity
The minimum inhibitory concentrations (MIC) for blank and AMB-loaded nanoparticle 
and the Sigma-Aldrich AMB solution were determined via the broth micro dilution 
method using 96-well plates according to document M27-A3, from the Clinical and 
Laboratory Standards Institute-CLSI (formerly NCCLS) [51]. Stock solution of 




























































range 0.007 – 16 μg.mL-1 in RPMI 1640 medium. AMB (0.007 - 16 μg.mL-1) was used 
as a standard. The microplates were incubated at 35°C and fungal growth/inhibition was 
observed after 48 h. The MIC was defined as the lowest concentration of an 
antimicrobial agent that prevents visible growth of a microorganism. The results were 
read visually as recommended by CLSI [51]. Each experiment was performed in 
duplicate. Four Candida albicans strains were used in the experiment, one obtained 
from the American Type Culture Collection (ATCC 90028) and three from  clinical 
isolates of C. albicans obtained from Santa Casa de Misericórdia Hospital, Sobral 
(Ceará, Brazil).
3. Results and discussion
The grafting of L-lactide onto CG chains involves a nucleophilic attack by the 
hydroxyl groups of the polysaccharide. Since the hydroxyl groups are not sufficiently 
nucleophilic to initiate the reaction, the production of a reactive alkoxide is required. 
This wascarried out through the addition of triethylamine (TEA), as suggested by Cho 
et al. [13]. TEA also acts as a catalyst for the lactide ring-opening reaction.
3.1. Cashew gum graft reaction yield
The reaction yield was higher for CGPLA 1:1 than for CGPLA 1:10 (Table 2), 
indicating that an increase in the amount of L-lactide in the reaction medium leads to a 
decrease in the yield. The CGPLA was purified in order to remove the homopolymer 
produced in a side reaction. Purification of the copolymer was carried out by polylactide 
extraction with a non solvent. Several authors have reported the use of organic solvents, 
such as chloroform [15], toluene [7,52,53], acetone [54] and hexane [49,55], to remove 
the polylactide, or a solvent mixture like toluene/methanol [56]. In this study, hexane 
was chosen to remove the homopolymer. CGPLA copolymers are not soluble in this 




























































unpurified copolymer, also decreased with increasing of CG:PLA molar ratio.  An 
increase in the proportion of lactide in the reaction favored the formation of the 
homopolymer. The percentage (%) of grafting observed for the chitosan-g-poly(lactic 
acid) derivative at a chitosan:PLA ratio of 10:1 was higher (92.49%) than that observed 
for CGPLA in the same feed ratio [10].  Cellulose graft with PLA copolymers, with a 
feed ratio of 1:1, show an increase in the grafting from 27.88 to 32.63 % on varying the 
reaction temperature from 130 to 110˚C [5]. These values were also higher than that 
obtained with a CG:PLA ratio of 1:1. In both cited articles, stannous octoate was used 
as the catalyst and high temperatures were employed (110-140 ˚C). In the CGPLA 
synthesis triethylamine (TEA) was used as a catalyst with the temperature ranging from 
70-75°C. 
3.2. FTIR analysis
FTIR spectrafor the PLA, CG and copolymers are shown in Fig. S1-Supplementary 
material.The PLA spectrum shows intense bands in the range from 2971 to 2853cm-1 
and at 1739 cm-1. The bands at 2971and 2853cm-1 are due to the asymmetric and 
symmetric stretching vibration of CH3, while the band at 2853 cm-1 is related to the 
symmetric vibration of aliphatic CH groups. The intense band at 1739 cm-1 is attributed 
to the C=O stretching vibration of aliphatic ester groups [56]. The cashew gum 
spectrum (in salt form) shows a broad band at 3379 cm-1 due to O–H stretching 
vibrations. Strong bands at 1150, 1080 and 1030 cm-1are due to stretching vibrations of 
C–O–C from glycosidic bonds and the bending of O–H from alcohols, characteristic of 
polysaccharide structures. A weak band at 2937 cm-1 was attributed to C–H stretching 
vibrations. The absorption at 1647 cm-1 is due to the O–H scissor vibrations of bonded 
water molecules and the shoulders at ~1600 and 1414 cm-1 can be attributed to 
asymmetrical and symmetrical –COO- vibrations of the uronic acid present in the gum 
[57-59].
In the copolymers, the presence of a new band at 1739 cm-1, as well as other bands 
characteristic of CG polysaccharide (e.g., 3379, 1150, 1080, 1030 cm-1) confirms the 





























































The NMR spectrum for cashew gum without modification shows characteristic 
anomeric protons in the region of 4.4 to 5.0 ppm using D2O as a solvent [73]. The 
signals in this region are reported to be due to -D-glucose (4.95 ppm), -L-rhamnose 
(4.81 ppm), -D-galactose (1→3) (4.69 ppm and 4.43 ppm) and -D-glucuronic acid 
(4.51 ppm). The H-2 to H-5 signals are overlapped in the regions of 3.4 ppm to 4.3 ppm 
and a quartet signal in the region of 1.26 ppm is due to the methyl protons of rhamnose 
[60].
Several polysaccharide/PLA graft copolymers have been investigated using 1H-NMR 
spectroscopy. The insertion of PLA leads to signals characteristic of terminal and 
internal backbone methyl groups at 1.3 ppm (A structure in Fig. 1) and 1.4 ppm (B 
structure in Fig. 1), respectively. The signals at 5.2 ppm (C structure in Fig. 1) and 4.2 
ppm (D structure in Fig. 1) were attributed to internal and terminal methine protons of 
PLA, respectively [7,9,11,61].
Fig.1 also shows the 1H- NMR spectra for the CGPLAP copolymers in DMSO-d6. 
Signals due to the lactide insertion into the cashew gum structure, at 1.31, 1.44, 4.2 and 
5.4 ppm, and signals associated with the anomeric protons of cashew gum in DMSO-d6 
(in the region of 5.04 to 5.17 ppm) were observed. The signal associated with the 
terminal methyl groups at 1.31 ppm is overlapped with that of the methyl groups of 
rhamnose present in the CG. The presence of the PLA signals related tointernal and 
terminal groups indicates that the PLA chain is grafted onto the CG structure[11] and 
the absence of a signal at 1.66 ppm, characteristic of the lactide monomer [12], suggests 
the absence of residual monomer in the purified copolymers.
The values for MS, DS and DP, based on equations 1 to 3, are reported in Table 2. 
These values show that the increase in lactide content does not increase the percentage 
of grafting, since only a small difference can be observed in these values. However, a 
slight increase in the DP was observed for a CGPLAP ratio of 1:10. The variation in the 
DP values may lead to different nanoparticle aggregation pattern. This result differs 
from that obtained for the pullulan graft PLA[12,13], where an increase in the 
PLA:glycosidic repeating unit ratio from 5:1 to 20:1 led to an increase in the DS (from 
0.45 to 0.65). However, the DS values obtained for the CGPLAP copolymers are higher 




























































3.4. Particle size 
The nanoparticles were prepared via self-organization using DMSO as the solvent. 
The hydrodynamic diameter, in an aqueous medium, was determined by DLS at 25 ºC. 
Nanoparticle (NP) size distributions for both copolymers are monomodal (see Fig. S2-
Supplementary material). The Z-average diameters in distilled water for NP sobtained 
with CGPLAP molar ratios of 1:1 and 1:10 were 230.4 ± 7.7 and 243.6 ± 10.7 nm, 
respectively. The PDI values were 0.272 ± 0.002 and 0.307 ± 0.018, respectively for 
NPs obtained with ratios of 1:1 and 1:10, indicating a narrow size distribution. The 
CGPLAP 1:10 NPs had a higher PDI value than the CGPLAP 1:1 NPs. An increase in 
the feed ratio does not affect significantly the hydrodynamic size of the self-assembled 
CGPLAP nanoparticles. The zeta potentials for the two copolymers were also similar (-
26.1 ± 1.9 and -24.3 ± 2.3 mV, respectively, for the CGPLAP copolymers 1:1 and 1:10).
In our previously work [36] we produced Pickering emulsion with monomodal 
distribution with CGPLAP 1:1 sample using Miglyol as oil phase. The particle size 
value of this Pickering emulsion was closer to that obtained by self-assembling (241 ± 5 
nm). Graft copolymer of PLA with other polysaccharide such chitosan [18], pullulan 
[11,12], and chondroitin sulfate [61] have been synthesized and characterized by DLS. 
Chitosan-g-PLA nanoparticles were produced by dialysis and dialysis plus 
ultrasonification [16]. Dialysis methods led to a particle size of 569 nm, however, when 
these particles were submitted to ultra sonification with different amplitude and time, 
particles size ranging from 200 to 350 nm were obtained. For pullulan-g-PLA 
copolymers nanoparticles prepared with similar methods used in the present work, the 
particle size decrease with the increase of degree of substitution (DS) ranging from 341 
to 202 nm depending on DS [11]. Chondroitin sulfate-g-PLA copolymers nanoparticle 
were prepared by emulsification (O/W emulsion) with particle size ranging from 92.1 to 
108.5 nm,when the of proportion chondroitin sulfate increase in the copolymer the 
particle size decrease [62]. 
The stability of the nanoparticles in physiological buffer (pH 7.4 at 37 ˚C) over 6 h 
was determined by measuring the particle size (Fig.2) to observe whether aggregation 
occurred during this period. It can be observed that the copolymers nanoparticles in 
buffer pH 7.4 (231.4 ± 17.3 and 226.5 ± 18.2 nm for CGPLAP 1:1 and 1:10), 




























































The particle size remained almost constant for up to 240 min for both copolymers 
(Fig. 2a), and the CGPLAP 1:1 NPs are slightly larger compared with the CGPLAP 
1:10 NPs. After this time, the CGPLAP 1:1 NPs started to aggregate, as observed by the 
increase in the particle size, however,size distribution is still monodisperse (Figs 2b and 
2c). The higher stability of the CGPLAP 1:10 NPs may be related to the DP or different 
substitution patterns at the CG chain.
3.5. Nanoparticles Morphology
SEM and AFM micrographs show that the nanoparticles have spherical shape with a 
smooth surface (Fig. 3a, 3b, 3c and 3d) and the average nanoparticle sizes are 
significantly smaller than that obtained by DLS, approximately 70 nm for both 
CGPLAP 1:1 and CGPLAP 1:10 (Fig 3e and 3f). These differences may be due to the 
fact that AFM and SEM determine the diameter of the dry particles, and will probably 
cause them to shrink, whereas the DLS determines the hydrodynamic diameter in 
aqueous solution, which leads to swelling of the samples and consequently larger 
particles sizes. 
 Amplitude and phase images were show in Fig 4. The CGPLAP 1:1 samples are 
extremely homogeneous, showing no phase difference (Fig 4a and 4c), whereas 
CGPLAP 1:10 NP´s have texture in phase (Fig 4b and 4d). This can be explained by the 
slight increase in DP, observed for CGPLAP 1:10, that increase PLA chain. The 
variation on the hydrophobicity may lead to phase difference on the AFM images of 
CGPLAP 1:10.  
3.6. Amphotericin B (AMB) encapsulation and loading efficiency (LE)
The other important aspect to evaluate for the CGPLAP nanoparticles was their 
capacity to associate AMB, a drug of low water solubility.The use of nanocapsules is 
reported for protection of different systems in pharmaceutical or cosmetic applications, 
especially for substances that degrade at temperatures above 40 °C or are sensitive to 
oxidation in the presence of water, pH variation or ultraviolet light[63].The loading 
efficiency were 89.7 and 82.7 (%) for CGPLAP 1:1 and 1:10, respectively. It can be 
seen that the efficiency value was slightly lower for the GCPLAP 1:10 systems. 




























































lower encapsulation efficiency (21 to 47 % respectively for Pickering emulsion 
stabilized with CGPLAP 1:1 and 1:10) compared with self-assembling nanoparticles 
[36]. 
Other authors also reported high values for encapsulation efficiency, confirming that 
amphiphilic systems are efficient in incorporating amphotericin B. Polycarbonate 
micelles obtained LE values (%) ranging from 66.4 to 76.4 % [44]. AMB-containing 
PLA-PEG nanoparticles were successfully obtained by the emulsion-solvent 
evaporation method. The mean diameter in the NPs was 223 ± 25 nm and the 
encapsulation efficiency were 68.9% [64]. Micelles of linolenic acid-modified PEG-
oligochitosan conjugates prepared by dialysis method has 82.27 ± 1.96 % of drug 
encapsulation efficiency [65]. Nanoparticles of PLGA has efficiency loading 
approximately 80 %[66]. So our samples were very efficiently in the encapsulation of 
AMB in comparison with other systems. 
AMB tends to aggregate in commercial formulations, leading to an increase of toxicity. 
The UV spectroscopy was used to determinate the aggregation states of AMB when 
encapsulated in nanoparticles. The UV-vis for AMBin DMSO and a commercial 
solution of AMBfrom Sigma Aldrich (2x10-5 mol.L-1) in water are show in Fig. 5a. 
Bands located at 407-419 nm (Band IV) is the characteristic peak for monomeric form 
of AMB, while Band I, at approximately 330-340 nm, represents the aggregated form 
[45]. The spectrum for AMB in DMSO showed high intensity peaks at 370, 391 and 
415 nm, representing the monomeric form and a low intensity peak at 353 nm. In 
contrast, the absorbance spectrum for the commercial AMB solution in water showed a 
high intensity peak at 327 nm, which represent the aggregate state of AMB and peaks of 
low intensity at 362, 385 and 408 nm. 
The UV-vis for the CGPLAP nanoparticles can be seenin Fig 5 band showed a broad 
peak of high intensity at 332 nm for both copolymers (GCPLAP 1:1 and 1:10).  Lower 
intense peaks were observed at 362, 388 and 419 nm. Spectra with similar absorption 
profiles were found in polycarbonate micelles [44],cluster dextrin [67], linolenic acid-
modified and oligochitosan conjugates micelles [65] and PLGA nanoparticles [66].
In general, the spectral changes induced by the aggregation of AMB may be 
represented as the value of the ratio of the intensities of the major absorption bands at λ 
= 348 and 409 nm (i.e., ∼A348/∼A409 ratio). This ratio assumes a value ≥2.0 for AMB  




























































In commercial formulations of AMB (e.g., Amphocil®, Fungizone®, Abelcet® and 
AMBisone®) A348/A409 ratios were reported as9.1, 4.8, 1.3 and 2.9, respectively [69] 
thus reflecting that AMB occurs in the aggregated form in such all cases, been 
Abelcet® and AMBisone® in less aggregated form. The A332/A419 ratio values for the 
CGPLAP 1:1 (A332/A419 ratio 3.18) and 1:10(A332/A419 ratio 3.28) nanoparticles indicate 
that the AMB loaded in CGPLAP nanoparticles are in aggregate form, however they are 
in a less aggregated state than the observed for Amphocil®, Fungizone® [69]. If 
compared with commercial AMB solution from Sigma-Aldrich (A332/A419 ratio 6.12) 
values obtained for the CGPLAP copolymers are almost half of the value. 
CGPLAP Pickering emulsion was more effective in loaded AMB without 
aggregation than the nanoparticles produced by self-assembling [36]. The values of 
A348/A409 was 1.7 and 1.6 respectively for CGPLAP 1:1 and 1:10 copolymers Pickering 
emulsion [36].
The size, PDI and zeta potential for the CGPLAP nanoparticles unload and load with 
AMB and for commercial AMB solution (Sigma-Aldrich) is shown in Fig 6. It was 
possible to observe an expressive increase in the particle size with AMB encapsulation 
for both systems, with values of 230.4 ± 7.7 and 243.6 ± 10.7 nm for unloaded and 1192 
± 23.6 and 1025 ± 143 nm for loaded AMB respectively for CGPLAP 1:1 and 1:10 
nanoparticle. This occurs, probably due to electrostatic interferences of the drug with 
the polymer chain during the formation of the nanoparticles [14]. The commercial AMB 
solution appeared almost four times larger than the two nanoparticle systems, with a 
value of 3682 ± 231 nm. 
When evaluating the PDI for the nanoparticles, there is a decrease in their values for 
both, from 0.277 to 0.096 for the nanoparticle CGPLAP 1: 1 and from 0.307 to 0.254 
for the nanoparticle CGPLAP 1:10. This indicates that the AMB load into the 
nanoparticles causes the particle size to become more homogeneous. The commercial 
AMB solution has a higher PDI value (0.413 ± 0.06) than the CGPLAP nanoparticles.
The zeta potential is another important parameter because indicates the stability of 
nanoparticles and provides the aggregation. For unload CGPLAP 1:1 and 1:10 
nanoparticles, has a zeta potential of -26.1 ± 1.9 and -24.3 ± 2.3 mV, respectively. For 
the load AMB nanoparticles has a decrease in zeta potential value of -10.3 ± 0.2 and -




























































commercial AMB is close to that of nanoparticles without AMB, with a value of -22.4 ± 
0.9 mV.
3.7Biocompatibility assessment 
The extent of hemolysis caused after incubation with RBCs is show in Fig 7 for 
CGPLAP 1:1, CGPLAP 1:10 blank and AMB loaded nanoparticles and commercial 
AMB. Incubation of RBCs with triton X (0.1%), as a positive control, led to lysis in red 
cells instantly, causing 100% hemolysis and releasing hemoglobin, which causes the 
solution to become cloudy after centrifugation, saline solution (0.9%) was used as 
negative control. Commercial AMB solution shows a large extent of erythrocyte 
damage.
It can be observed for blank nanoparticles (in this case concentration is the 
copolymer concentration), in the all concentrations studied, there is no statistical 
difference between CGPLAP 1:1 and CGPLAP 1:10 nanoparticles, with hemolysis 
extended less than 5%, indicating excellent biocompatibility for nanoparticles matrix. 
For AMB loaded copolymers the concentration in Fig. 7 refers to AMB 
concentration. Statistical analysis using Tukey test revealed that the differences between 
CGPLAP 1:1 + AMB and CGPLAP 1:10 + AMB nanoparticles were significant (P < 
0.05) when the AMB concentrations were 250 and 125 µg.mL-1.
 CGPLAP 1:1 + AMB has a lower percentage of hemolysis (47.0 ± 3.7 and 2.7 ± 1.4 
% respectively for 250 and 125 µg.mL-1 AMB concentrations) than CGPLAP 1:10 + 
AMB (85.9 ± 4.2 and 20.5 ± 5.3 % respectively for 250 and 125 µg.mL-1 AMB 
concentrations). Despite the high hemolysis for CGPLAP 1:10 + AMB (85.9 ± 4.2 % at 
AMB concentration of 250 µg.mL-1), the damage is lower than for commercial AMB 
(109.8 ± 2.2 %) at the same concentration (250 µg.mL-1). 
When the AMB concentration was decrease to 62.5 µg.mL-1, no difference statistical 
was observed for CGPLAP 1:1 + AMB and CGPLAP 1:10 + AMB, with a hemolysis 
extended less than 5 %. CGPLAP 1:1 + AMB exert a stabilizing and protective effect 






























































To investigate the potential CGPLAP nanoparticles as AMB drug delivery devices, 
an in vitro release experiment was carried out using PBS buffer with 0.25 % sodium 
lauryl sulfate as release medium (Fig 8). 
The release profile shows a sustained drug delivery, with maximal release percentage 
of 42.6 ± 4.5 and 52.2 ± 3.9 % after 168 h, for CGPLAP 1:1 and CGPLAP 1:10, 
respectively. The highest release percentage was obtained for CGPLAP 1:10 
nanoparticles, probably due to its lower DS (1.10), which promotes less interaction with 
AMB, releasing a higher amount of drug. 
Similar release profile is found for chitosan and AMB complex, releasing 
approximately 21% in the first 24 h, followed by 44.5% release after 20 days of 
experiment [70].
 3.9In vitro antifungal test
Unloaded CGPLAP nanoparticles showed inhibition activity against all C. 
albican strains (Table 3). The minimum inhibitory concentration (MIC) values for 
CGPLAP 1:1 was similar to that of commercial amphotericin B. As far as we concern 
no previous report on polylactideantifungal activity has been reported MIC values of 
AMB-loaded CGPLAP 1:1  and 1 : 10 (Table 3) are half the figure observed for 
commercial AMB solution, a fact that may be due to a synergistic effect of copolymer 
which also exhibits antifungal activity. These results indicate that CGPLAP 
nanoparticles have great potential as nanocarrier delivery system.
4. Conclusions
Copolymers of cashew gum and L-Lactide were synthesized using two CG:PLA 
molar ratios. Nanoparticles were produced through equilibrium dialysis using DMSO as 
a solvent. The copolymer nanoparticles have similar particle size and zeta potential. The 




























































distribution. The potential use of CGPLAP nanoparticles as drug delivery device was 
tested using AMB as a proof-of concept. A high efficiency of encapsulation was 
obtained if compared with CGPLAP Pickering emulsion system previously reported, 
however AMB was more aggregated in the self-assembling nanoparticle than in 
Pickering emulsion, but less than in Fungizone®. Unloaded CGPLAP nanoparticles 
showed inhibition activity against all C. albican strains. MIC values of AMB-loaded  
CGPLA are smaller than that observed for commercial AMB solution, a fact that may 
be due to a copolymer synergistic effect, indicating that the system has a good potential 
as AMB  nanocarrier delivery.
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Fig. 1. 1H NMR spectra for CGPLAP 1:10 and CGPLAP 1:1 in DMSO-d6
Fig. 2. Stability of copolymers and particle size distributionover time (a), particle size 
distribution of  CGPLAP 1:1 (b) and CGPLAP 1:10 (c) nanoparticles in phosphate 
buffer 7.4 at 37 °C. 
Fig 3. SEM micrographs of CGPLAP 1:1 (a) and CGPLAP 1:10 (b). AFM 
measurements of blank nanoparticles.AFM micrograph height images of CGPLAP 
1:1(c)  andCGPLAP 1:10 (d) and AFM histograms graphics of CGPLAP 1:1(e)  and 
CGPLAP 1:10(f) blank nanoparticles. 
Fig. 4 AFM images of amplitude for (a) CGPLAP 1:1 and (b) CGPLAP 1:10 and phase 
images of (c) CGPLAP 1:1 and (d) CGPLAP 1:10 blank nanoparticles. 
Fig. 5UV-Vis spectra ofAMB in DMSO and a commercial AMB aqueous 
solution(Sigma-Aldrich) (a) and AMB loaded CGPLAP nanoparticles aqueous solution 
(b).
Fig 6. Effect of AMB load on size, PDI and zeta potential for the CGPLAP 
nanoparticles.
Fig. 7.Hemolysis percentage as a function of concentration for CGPLAP 1:1 and 
CGPLAP 1:10 nanoparticles commercial AMB. Triton was used as a positive control.
Fig 8. In vitroAMB release profile for CGPLA nanoparticlesnanocapsule in PBS buffer 





































































Table 1 - Amount of reagents and solvent used for the synthesis of CGPLAP 
copolymers
gum:L-lactide molar ratioa DMSO (mL) L-Lactide (g) TEA (mL)
1:1 8.89 0.889 0.178
1:10 88.9 8.89 1.78
aAmount of cashew gum was maintained at 1.0 g





Reaction yield (%)a 66.5 ± 1.2 14.8 ± 0.7
Copolymer yield (%)b 98.2± 1.4 87.7 ± 5.4
Homopolymer yield (%)b 1.8 ± 1.4 12.3 ±5.4




a In relation to initial weight of CG+PLA; b in relation to unpurified copolymer; cmass 
of copolymer-mass of CG/mass of purified copolymer. MS, DS, and DP were calculated 
as described in equations 1 to 3.










CGPLAP 1:1blanka 2 2 2 2
CGPLAP 1:10 blanka 1 1 1 1
AMB loaded CGPLAP 1:1 0.25 0.5 0.5 0.5
AMB loaded CGPLAP 1:1 0.5 0.5 0.5 0.5
AMB (Sigma) 1 1 1 1
a Copolymer concentration
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